Norton, Larry

Publications

Sort by

Co-Author Network

selected publications

The Genomic Landscape of Mucinous Breast Cancer. Journal of the National Cancer Institute. 2019 Academic Article GET IT
Times cited: 51
A Tribute to John Mendelsohn: A Pioneer in Targeted Cancer Therapy. Cancer research. 2019 Review GET IT
Times cited: 6
Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia. JAMA dermatology. 2019 Academic Article GET IT
Times cited: 38
Pathologic complete response rate according to HER2 detection methods in HER2-positive breast cancer treated with neoadjuvant systemic therapy. Breast cancer research and treatment. 2019 Academic Article GET IT
Times cited: 31
Supporting data sharing. NPJ breast cancer. 2019 Editorial Article GET IT
Times cited: 2
Phase II Study of Weekly Paclitaxel with Trastuzumab and Pertuzumab in Patients with Human Epidermal Growth Receptor 2 Overexpressing Metastatic Breast Cancer: 5-Year Follow-up. The oncologist. 2019 Academic Article GET IT
Times cited: 3
Reply to "Multicentric Ipsilateral Invasive Breast Carcinomas Might Have Higher 21-Gene Recurrence Score Compared with Multifocal Ipsilateral Invasive Breast Carcinomas". Annals of surgical oncology. 2018 Letter GET IT
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle. Annals of oncology : official journal of the European Society for Medical Oncology. 2018 Academic Article GET IT
Times cited: 15
Multifocal/Multicentric Ipsilateral Invasive Breast Carcinomas with Similar Histology: Is Multigene Testing of All Individual Foci Necessary?. Annals of surgical oncology. 2018 Academic Article GET IT
Times cited: 7
Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancer. Nature communications. 2018 Academic Article GET IT
Times cited: 118
The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers. Cancer cell. 2018 Academic Article GET IT
Times cited: 465
The Landscape of Somatic Genetic Alterations in Breast Cancers From ATM Germline Mutation Carriers. Journal of the National Cancer Institute. 2018 Academic Article GET IT
Times cited: 75
Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors. Nature communications. 2018 Academic Article GET IT
Times cited: 68
4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†. 2018 GET IT
Times cited: 779
Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas. Nature communications. 2018 Academic Article GET IT
Times cited: 96
Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer. Clinical breast cancer. 2018 Academic Article GET IT
Times cited: 29
The 21-Gene Recurrence Score in Male Breast Cancer. Annals of surgical oncology. 2018 Academic Article GET IT
Times cited: 11
Breast carcinoma with 21-gene recurrence score lower than 18: rate of locoregional recurrence in a large series with clinical follow-up. BMC cancer. 2018 Academic Article GET IT
Times cited: 10
MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene. The Journal of pathology. 2017 Academic Article GET IT
Times cited: 52
3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3). Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Academic Article GET IT
Times cited: 75
Genomic and transcriptomic heterogeneity in metaplastic carcinomas of the breast. NPJ breast cancer. 2017 Academic Article GET IT
Times cited: 41
An Akt3 Splice Variant Lacking the Serine 472 Phosphorylation Site Promotes Apoptosis and Suppresses Mammary Tumorigenesis. Cancer research. 2017 Academic Article GET IT
Times cited: 11
Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 2017 Academic Article GET IT
Times cited: 408
Pan-cancer analysis of bi-allelic alterations in homologous recombination DNA repair genes. Nature communications. 2017 Academic Article GET IT
Times cited: 147
Monosomy 17 in potentially curable HER2-amplified breast cancer: prognostic and predictive impact. Breast cancer research and treatment. 2017 Academic Article GET IT
Times cited: 20
Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017 Academic Article GET IT
Times cited: 156
21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer. Breast cancer research and treatment. 2017 Academic Article GET IT
Times cited: 27
The 21-gene recurrence score in special histologic subtypes of breast cancer with favorable prognosis. Breast cancer research and treatment. 2017 Academic Article GET IT
Times cited: 20
Genetic analysis of uterine adenosarcomas and phyllodes tumors of the breast. Molecular oncology. 2017 Academic Article GET IT
Times cited: 10
Sleep problems in breast cancer survivors 1-10 years posttreatment. Palliative & supportive care. 2017 Academic Article GET IT
Times cited: 60
American Society of Clinical Oncology Position Statement: Strategies for Reducing Cancer Health Disparities Among Sexual and Gender Minority Populations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Academic Article GET IT
Times cited: 120
Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017 Academic Article GET IT
Times cited: 78
Pathologic Complete Response with Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Paclitaxel with Trastuzumab and Pertuzumab in Patients with HER2-Positive Early Stage Breast Cancer: A Single Center Experience. The oncologist. 2017 Academic Article GET IT
Times cited: 24
Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples. Nature medicine. 2017 Academic Article GET IT
Times cited: 91
The Landscape of Somatic Genetic Alterations in Metaplastic Breast Carcinomas. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017 Academic Article GET IT
Times cited: 100
Dealing with the tyranny of certainty in the (medical) digital age. Psycho-oncology. 2017 Academic Article GET IT
Corrigendum to "3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)" [Breast 31 (February 2017) 244-259]. Breast (Edinburgh, Scotland). 2017 Academic Article GET IT
Times cited: 3
3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3). 2017 GET IT
Times cited: 337
The genetic landscape of breast carcinomas with neuroendocrine differentiation. The Journal of pathology. 2016 Academic Article GET IT
Times cited: 45
3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3). 2016 GET IT
Times cited: 160
Massively parallel sequencing analysis of synchronous fibroepithelial lesions supports the concept of progression from fibroadenoma to phyllodes tumor. NPJ breast cancer. 2016 Academic Article GET IT
Times cited: 22
Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2016 Academic Article GET IT
Times cited: 39
A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer. Cancer discovery. 2016 Academic Article GET IT
Times cited: 35
Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after Immunotherapy. Cancer immunology research. 2016 Academic Article GET IT
Times cited: 104
A Pilot Study of Preoperative Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer with Comprehensive Immune Profiling. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016 Academic Article GET IT
Times cited: 128
A Rare Case of S310F Somatic ERBB2 Mutation in a HER2-Nonamplified Breast Cancer. 2016 GET IT
Times cited: 11
Breast carcinoma with an Oncotype Dx recurrence score <18: Rate of distant metastases in a large series with clinical follow-up. Cancer. 2016 Academic Article GET IT
Times cited: 14
Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: overall survival and updated progression-free survival results from a phase II study. Breast cancer research and treatment. 2016 Academic Article GET IT
Times cited: 28
Cold thermal injury from cold caps used for the prevention of chemotherapy-induced alopecia. Breast cancer research and treatment. 2016 Academic Article GET IT
Times cited: 15
TNF is a key cytokine mediating neutrophil cytotoxic activity in breast cancer patients. NPJ breast cancer. 2016 Academic Article GET IT
Times cited: 19
Decreased gastrointestinal toxicity associated with a novel capecitabine schedule (7 days on and 7 days off): a systematic review. NPJ breast cancer. 2016 Academic Article GET IT
Times cited: 8
JAK2 inhibition sensitizes resistant EGFR-mutant lung adenocarcinoma to tyrosine kinase inhibitors. Science signaling. 2016 Academic Article GET IT
Times cited: 50
Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Academic Article GET IT
Times cited: 55
The Genomic Landscape of Male Breast Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016 Academic Article GET IT
Times cited: 103
Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2016 Academic Article GET IT
Times cited: 75
Cardiac Surveillance Guidelines for Trastuzumab-Containing Therapy in Early-Stage Breast Cancer: Getting to the Heart of the Matter. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Review GET IT
Times cited: 75
Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression. The Journal of pathology. 2016 Academic Article GET IT
Times cited: 89
PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance). NPJ breast cancer. 2016 Academic Article GET IT
Times cited: 68
Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss. Genes & development. 2015 Academic Article GET IT
Times cited: 416
Cell-to-cell communication in cancer: workshop report. NPJ breast cancer. 2015 Academic Article GET IT
Times cited: 1
Biomarkers That Predict Sensitivity to Heat Shock Protein 90 Inhibitors. Clinical breast cancer. 2015 Academic Article GET IT
Times cited: 10
Spatiotemporal progression of metastatic breast cancer: a Markov chain model highlighting the role of early metastatic sites. NPJ breast cancer. 2015 Academic Article GET IT
Times cited: 27
A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast Cancer. Clinical breast cancer. 2015 Academic Article GET IT
Times cited: 1
Disabling of the erbB Pathway Followed by IFN-γ Modifies Phenotype and Enhances Genotoxic Eradication of Breast Tumors. Cell reports. 2015 Academic Article GET IT
Times cited: 19
The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study. The Journal of pathology. 2015 Academic Article GET IT
Times cited: 45
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. Lancet (London, England). 2015 Review GET IT
Times cited: 496
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet (London, England). 2015 Review GET IT
Times cited: 897
Breast cancer survivors are at an increased risk for osteoporotic fractures not explained by lower BMD: a retrospective analysis. NPJ breast cancer. 2015 Academic Article GET IT
Times cited: 7
Genomic landscape of adenoid cystic carcinoma of the breast. The Journal of pathology. 2015 Academic Article GET IT
Times cited: 113
Somatic mutations in leukocytes infiltrating primary breast cancers. NPJ breast cancer. 2015 Academic Article GET IT
Times cited: 21
Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration. Annals of oncology : official journal of the European Society for Medical Oncology. 2015 Review GET IT
Times cited: 157
Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification. Genome biology. 2015 Academic Article GET IT
Times cited: 100
Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer. 2015 GET IT
Times cited: 18
Corrigendum: metastatic breast carcinomas display genomic and transcriptomic heterogeneity. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2015 Article GET IT
Times cited: 5
Current management of lesions associated with an increased risk of breast cancer. Nature reviews. Clinical oncology. 2015 Review GET IT
Times cited: 92
Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Academic Article GET IT
Times cited: 66
Mesothelin expression in triple negative breast carcinomas correlates significantly with basal-like phenotype, distant metastases and decreased survival. PloS one. 2014 Academic Article GET IT
Times cited: 64
Metaplastic breast carcinomas display genomic and transcriptomic heterogeneity [corrected]. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2014 Academic Article GET IT
Times cited: 57
Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations. Genome biology. 2014 Academic Article GET IT
Times cited: 97
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands. Nature genetics. 2014 Academic Article GET IT
Times cited: 161
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2). Breast (Edinburgh, Scotland). 2014 Conference Paper GET IT
Times cited: 256
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†. Annals of oncology : official journal of the European Society for Medical Oncology. 2014 Academic Article GET IT
Times cited: 313
The AURORA initiative for metastatic breast cancer. British journal of cancer. 2014 Review GET IT
Times cited: 73
The effects of soy supplementation on gene expression in breast cancer: a randomized placebo-controlled study. Journal of the National Cancer Institute. 2014 Academic Article GET IT
Times cited: 104
Serum metabolomic profiles evaluated after surgery may identify patients with oestrogen receptor negative early breast cancer at increased risk of disease recurrence. Results from a retrospective study. Molecular oncology. 2014 Academic Article GET IT
Times cited: 77
Advances in managing breast cancer: a clinical update. F1000prime reports. 2014 Review GET IT
Times cited: 2260
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle. Annals of oncology : official journal of the European Society for Medical Oncology. 2014 Academic Article GET IT
Times cited: 273
Genome Sequencing of Multiple Primary Tumors Reveals a Novel PALB2 Variant. 2014 GET IT
Times cited: 4
Comparison of doxorubicin and cyclophosphamide versus single-agent paclitaxel as adjuvant therapy for breast cancer in women with 0 to 3 positive axillary nodes: CALGB 40101 (Alliance). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Academic Article GET IT
Times cited: 63
Slug promotes survival during metastasis through suppression of Puma-mediated apoptosis. Cancer research. 2014 Academic Article GET IT
Times cited: 33
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet (London, England). 2014 Review GET IT
Times cited: 1466
Cancer log-kill revisited. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2014 Review GET IT
Times cited: 12
TGF-β-Id1 signaling opposes Twist1 and promotes metastatic colonization via a mesenchymal-to-epithelial transition. Cell reports. 2013 Academic Article GET IT
Times cited: 180
Acquired resistance to crizotinib from a mutation in CD74-ROS1. The New England journal of medicine. 2013 Letter GET IT
Times cited: 45
Long-term cardiac safety and outcomes of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab with and without lapatinib in patients with early breast cancer. Cancer. 2013 Academic Article GET IT
Times cited: 16
N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like properties. Oncogene. 2013 Academic Article GET IT
Times cited: 93
Association between bone mineral density and incidence of breast cancer. PloS one. 2013 Academic Article GET IT
Times cited: 20
Randomized phase II trial of weekly vs. every 2 weeks vs. every 3 weeks nanoparticle albumin-bound paclitaxel with bevacizumab as first-line chemotherapy for metastatic breast cancer. Clinical breast cancer. 2013 Academic Article GET IT
Times cited: 30
Epoetin alfa: to give or not to give. Journal of the National Cancer Institute. 2013 Editorial Article GET IT
The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis. Neoplasia (New York, N.Y.). 2013 Academic Article GET IT
Times cited: 329
Living with metastatic breast cancer: a qualitative analysis of physical, psychological, and social sequelae. The breast journal. 2013 Academic Article GET IT
Times cited: 73
Spreaders and sponges define metastasis in lung cancer: a Markov chain Monte Carlo mathematical model. Cancer research. 2013 Academic Article GET IT
Times cited: 63
DNA mismatch repair deficiency in breast carcinoma: a pilot study of triple-negative and non-triple-negative tumors. The American journal of surgical pathology. 2012 Academic Article GET IT
Times cited: 38
Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2012 Academic Article GET IT
Times cited: 156
Translating mathematical modeling of tumor growth patterns into novel therapeutic approaches for breast cancer. Journal of mammary gland biology and neoplasia. 2012 Review GET IT
Times cited: 12
Rare de novo germline copy-number variation in testicular cancer. American journal of human genetics. 2012 Academic Article GET IT
Times cited: 16
Can we really use retrospective subset analyses and surveillance, epidemiology, and end results data to drive clinical practice?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Letter GET IT
Times cited: 3
Six cycles of doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: Cancer and Leukemia Group B 40101. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Academic Article GET IT
Times cited: 69
A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell. 2012 Academic Article GET IT
Times cited: 786
p21CIP1 mediates reciprocal switching between proliferation and invasion during metastasis. Oncogene. 2012 Academic Article GET IT
Times cited: 36
Choosing the best trastuzumab-based adjuvant chemotherapy regimen: should we abandon anthracyclines?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Academic Article GET IT
Times cited: 34
Id4 protein is highly expressed in triple-negative breast carcinomas: possible implications for BRCA1 downregulation. Breast cancer research and treatment. 2012 Academic Article GET IT
Times cited: 33
1st International consensus guidelines for advanced breast cancer (ABC 1). Breast (Edinburgh, Scotland). 2012 Conference Paper GET IT
Times cited: 268
Self-seeding in cancer. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 2012 Review GET IT
Times cited: 28
Potent induction of tumor immunity by combining tumor cryoablation with anti-CTLA-4 therapy. Cancer research. 2011 Academic Article GET IT
Times cited: 207
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet (London, England). 2011 Review GET IT
Times cited: 2652
Tumor entrained neutrophils inhibit seeding in the premetastatic lung. Cancer cell. 2011 Academic Article GET IT
Times cited: 535
Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer. Breast cancer research and treatment. 2011 Academic Article GET IT
Times cited: 19
Randomised trial of expressive writing for distressed metastatic breast cancer patients. Psychology & health. 2011 Academic Article GET IT
Times cited: 46
Tumor self-seeding in breast cancer. Clinical advances in hematology & oncology : H&O. 2011 Academic Article GET IT
Times cited: 1
p53 Expression in node-positive breast cancer patients: results from the Cancer and Leukemia Group B 9344 Trial (159905). Clinical cancer research : an official journal of the American Association for Cancer Research. 2011 Academic Article GET IT
Times cited: 27
Adjuvant trastuzumab with chemotherapy is effective in women with small, node-negative, HER2-positive breast cancer. Cancer. 2011 Academic Article GET IT
Times cited: 76
Breast cancer tumor size, nodal status, and prognosis: biology trumps anatomy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Editorial Article GET IT
Times cited: 37
HSP90 inhibition is effective in breast cancer: a phase II trial of tanespimycin (17-AAG) plus trastuzumab in patients with HER2-positive metastatic breast cancer progressing on trastuzumab. Clinical cancer research : an official journal of the American Association for Cancer Research. 2011 Academic Article GET IT
Times cited: 347
Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer. Clinical breast cancer. 2011 Academic Article GET IT
Times cited: 109
Clinical implications of cancer self-seeding. Nature reviews. Clinical oncology. 2011 Review GET IT
Times cited: 231
Breast cancer methylomes establish an epigenomic foundation for metastasis. Science translational medicine. 2011 Academic Article GET IT
Times cited: 227
A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology. 2011 Academic Article GET IT
Times cited: 49
Phase 2 trial of a novel capecitabine dosing schedule in combination with bevacizumab for patients with metastatic breast cancer. Cancer. 2011 Academic Article GET IT
Times cited: 14
Troponin I and C-reactive protein are commonly detected in patients with breast cancer treated with dose-dense chemotherapy incorporating trastuzumab and lapatinib. Clinical cancer research : an official journal of the American Association for Cancer Research. 2011 Academic Article GET IT
Times cited: 126
A feasibility study of bevacizumab plus dose-dense doxorubicin-cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel in early-stage breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2011 Academic Article GET IT
Times cited: 25
MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. Genes & development. 2011 Academic Article GET IT
Times cited: 185
Cancer stem cells, EMT, and seeding: a rose is a rose is a rose?. Oncology (Williston Park, N.Y.). 2011 Comment GET IT
Times cited: 4
Intracystic papillary carcinoma of the breast: An in situ or invasive tumor? Results of immunohistochemical analysis and clinical follow-up. The American journal of surgical pathology. 2011 Academic Article GET IT
Times cited: 81
Dose dense cyclophosphamide, methotrexate, fluorouracil is feasible at 14-day intervals: a pilot study of every-14-day dosing as adjuvant therapy for breast cancer. Clinical breast cancer. 2010 Academic Article GET IT
Times cited: 5
Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology Group. Medical oncology (Northwood, London, England). 2010 Academic Article GET IT
Times cited: 12
Dose-dense chemotherapy for breast cancer: what does the future hold?. Future oncology (London, England). 2010 Review GET IT
Times cited: 8
Capecitabine dosing is not yet optimized for breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology. 2010 Letter GET IT
Times cited: 2
Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amplified breast cancer is not feasible because of excessive diarrhea. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Academic Article GET IT
Times cited: 42
Germline BRCA mutations denote a clinicopathologic subset of prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2010 Academic Article GET IT
Times cited: 222
Optimizing chemotherapy dose and schedule by Norton-Simon mathematical modeling. Breast disease. 2010 Academic Article GET IT
Times cited: 25
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. Journal of the National Cancer Institute. Monographs. 2010 Review GET IT
Times cited: 521
Tumor self-seeding by circulating cancer cells. Cell. 2009 Academic Article GET IT
Times cited: 1048
Dose-dense adjuvant Doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 25
Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab-resistant tumors and suppress their growth. Oncogene. 2009 Academic Article GET IT
Times cited: 99
Feasibility trial of letrozole in combination with bevacizumab in patients with metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 42
Impact of high-dose chemotherapy on the ability to deliver subsequent local-regional radiotherapy for breast cancer: analysis of Cancer and Leukemia Group B Protocol 9082. International journal of radiation oncology, biology, physics. 2009 Academic Article GET IT
Times cited: 16
The 6q22.33 locus and breast cancer susceptibility. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2009 Review GET IT
Times cited: 22
Role of anthracyclines in the treatment of early breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Review GET IT
Times cited: 76
Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer cell. 2009 Academic Article GET IT
Times cited: 534
Adjuvant chemotherapy in older women with early-stage breast cancer. The New England journal of medicine. 2009 Academic Article GET IT
Times cited: 445
Anthracycline cardiotoxicity after breast cancer treatment. Oncology (Williston Park, N.Y.). 2009 Review GET IT
Times cited: 57
A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2008 Academic Article GET IT
Times cited: 103
Prolonged dose-dense epirubicin and cyclophosphamide followed by paclitaxel in breast cancer is feasible. Clinical breast cancer. 2008 Academic Article GET IT
Times cited: 11
A pilot study of dose-dense adjuvant paclitaxel without growth factor support for women with early breast carcinoma. Breast cancer research and treatment. 2008 Academic Article GET IT
Times cited: 11
Dose-dense chemotherapy with trastuzumab is an appropriate option. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Letter GET IT
Times cited: 1
Racial differences in clinical outcomes from metastatic breast cancer: a pooled analysis of CALGB 9342 and 9840--Cancer and Leukemia Group B. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Academic Article GET IT
Times cited: 30
Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Academic Article GET IT
Times cited: 60
Influence of activation state of ErbB-2 (HER-2) on response to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for stage II, node-positive breast cancer: study 8541 from the Cancer and Leukemia Group B. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Academic Article GET IT
Times cited: 6
Changing indications for surgery in patients with stage IV breast cancer: a current perspective. Cancer. 2008 Academic Article GET IT
Times cited: 19
Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Academic Article GET IT
Times cited: 531
Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17. Annals of oncology : official journal of the European Society for Medical Oncology. 2008 Academic Article GET IT
Times cited: 58
Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Academic Article GET IT
Times cited: 176
Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Academic Article GET IT
Times cited: 133
The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Academic Article GET IT
Times cited: 51
Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proceedings of the National Academy of Sciences of the United States of America. 2008 Academic Article GET IT
Times cited: 264
Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944). Breast cancer research and treatment. 2008 Academic Article GET IT
Times cited: 14
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Academic Article GET IT
Times cited: 488
Analysis of genetic variation in Ashkenazi Jews by high density SNP genotyping. BMC genetics. 2008 Academic Article GET IT
Times cited: 28
Dose-escalation of filgrastim does not improve efficacy: clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxel. Cancer treatment reviews. 2008 Academic Article GET IT
Times cited: 13
Cancer stem cells, self-seeding, and decremented exponential growth: theoretical and clinical implications. Breast disease. 2008 Academic Article GET IT
Times cited: 36
SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase-dependent cancers. Clinical cancer research : an official journal of the American Association for Cancer Research. 2008 Academic Article GET IT
Times cited: 158
Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2 overexpressing breast cancer: a phase I dose-escalation study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Academic Article GET IT
Times cited: 311
Tumor dormancy: separating observations from experimental science. Nature clinical practice. Oncology. 2007 Editorial Article GET IT
Times cited: 2
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Review GET IT
Times cited: 1918
Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer. Breast cancer research and treatment. 2007 Academic Article GET IT
Times cited: 27
Antibody and CD8+ T cell responses against HER2/neu required for tumor eradication after DNA immunization with a Flt-3 ligand fusion vaccine. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Academic Article GET IT
Times cited: 24
HER2 and response to paclitaxel in node-positive breast cancer. The New England journal of medicine. 2007 Academic Article GET IT
Times cited: 520
Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Academic Article GET IT
Times cited: 257
Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis. Annals of surgical oncology. 2007 Academic Article GET IT
Times cited: 77
Immunization of high-risk breast cancer patients with clustered sTn-KLH conjugate plus the immunologic adjuvant QS-21. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Academic Article GET IT
Times cited: 81
Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Academic Article GET IT
Times cited: 111
Keeping faith with trial volunteers. Nature. 2007 Academic Article GET IT
Increased dose density is feasible: a pilot study of adjuvant epirubicin and cyclophosphamide followed by paclitaxel, at 10- or 11-day intervals with filgrastim support in women with breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Academic Article GET IT
Times cited: 9
Novel patterns of genome rearrangement and their association with survival in breast cancer. Genome research. 2006 Academic Article GET IT
Times cited: 270
Pharmacokinetics and toxicity of weekly docetaxel in older patients. Clinical cancer research : an official journal of the American Association for Cancer Research. 2006 Academic Article GET IT
Times cited: 66
A phase I study of cetuximab/paclitaxel in patients with advanced-stage breast cancer. Clinical breast cancer. 2006 Academic Article GET IT
Times cited: 82
Is cancer a disease of self-seeding?. Nature medicine. 2006 Academic Article GET IT
Times cited: 288
The Norton-Simon hypothesis: designing more effective and less toxic chemotherapeutic regimens. Nature clinical practice. Oncology. 2006 Review GET IT
Times cited: 160
Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806. Breast cancer research and treatment. 2006 Academic Article GET IT
Times cited: 21
Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. JAMA. 2006 Academic Article GET IT
Times cited: 638
Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial. Breast cancer research and treatment. 2006 Academic Article GET IT
Times cited: 85
Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective. Breast cancer research and treatment. 2006 Academic Article GET IT
Times cited: 82
Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumours. Journal of clinical pathology. 2006 Academic Article GET IT
Times cited: 70
Localization of breast cancer susceptibility loci by genome-wide SNP linkage disequilibrium mapping. Genetic epidemiology. 2006 Academic Article GET IT
Times cited: 15
Nasal septum perforation in a bevacizumab-treated patient with metastatic breast cancer. 2006 GET IT
Times cited: 47
Use of dose-dense chemotherapy in the management of breast cancer. Clinical advances in hematology & oncology : H&O. 2006 Review GET IT
Times cited: 7
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet (London, England). 2005 Review GET IT
Times cited: 4109
Society for Integrative Oncology First International Conference, New York City, November 2004. Keynote address. Journal of the Society for Integrative Oncology. 2005 Academic Article GET IT
Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary. The American journal of surgical pathology. 2005 Academic Article GET IT
Times cited: 118
Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane. Cancer. 2005 Academic Article GET IT
Times cited: 165
Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families. Journal of the National Cancer Institute. 2005 Academic Article GET IT
Times cited: 78
Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17. Journal of the National Cancer Institute. 2005 Academic Article GET IT
Times cited: 1016
Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 99
Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy. Breast cancer research and treatment. 2005 Academic Article GET IT
Times cited: 45
A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxane. Clinical breast cancer. 2005 Academic Article GET IT
Times cited: 54
Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 97
Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA. 2005 Academic Article GET IT
Times cited: 351
A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancer. Breast cancer research and treatment. 2005 Academic Article GET IT
Times cited: 82
Dose-dense adjuvant chemotherapy for primary breast cancer. Breast cancer research : BCR. 2005 Academic Article GET IT
Times cited: 34
Serum HER2 extracellular domain in metastatic breast cancer patients treated with weekly trastuzumab and paclitaxel: association with HER2 status by immunohistochemistry and fluorescence in situ hybridization and with response rate. Annals of oncology : official journal of the European Society for Medical Oncology. 2005 Academic Article GET IT
Times cited: 112
Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: a clinic-based series. Cancer. 2005 Academic Article GET IT
Times cited: 123
Change in cycle 1 to cycle 2 haematological counts predicts toxicity in older patients with breast cancer receiving adjuvant chemotherapy. Drugs & aging. 2005 Academic Article GET IT
Times cited: 14
Conceptual and practical implications of breast tissue geometry: toward a more effective, less toxic therapy. The oncologist. 2005 Academic Article GET IT
Times cited: 137
Effect of creatinine clearance on patterns of toxicity in older patients receiving adjuvant chemotherapy for breast cancer. Drugs & aging. 2005 Academic Article GET IT
Times cited: 26
Phosphorylated/activated HER2 as a marker of clinical resistance to single agent taxane chemotherapy for metastatic breast cancer. Cancer investigation. 2005 Academic Article GET IT
Times cited: 38
Radiation pneumonitis in breast cancer patients treated with taxanes: does sequential radiation therapy lower the risk?. The breast journal. 2005 Academic Article GET IT
Times cited: 6
Two regimens of docetaxel for metastatic breast cancer. Current oncology reports. 2005 Comment GET IT
A tool for predicting breast carcinoma mortality in women who do not receive adjuvant therapy. Cancer. 2004 Academic Article GET IT
Times cited: 37
Effect of addition of adjuvant paclitaxel on radiotherapy delivery and locoregional control of node-positive breast cancer: cancer and leukemia group B 9344. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004 Academic Article GET IT
Times cited: 89
The NHL-15 protocol for aggressive non-Hodgkin's lymphomas: a sequential dose-dense, dose-intense regimen of doxorubicin, vincristine and high-dose cyclophosphamide. Annals of oncology : official journal of the European Society for Medical Oncology. 2004 Academic Article GET IT
Times cited: 16
Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. The New England journal of medicine. 2004 Academic Article GET IT
Times cited: 873
Cytokeratin-positive cells in sentinel lymph nodes in breast cancer are not random events: experience in patients undergoing prophylactic mastectomy. Cancer. 2004 Academic Article GET IT
Times cited: 39
Phase II study of feasibility of dose-dense FEC followed by alternating weekly taxanes in high-risk, four or more node-positive breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2004 Academic Article GET IT
Times cited: 29
Phase II study of celecoxib and trastuzumab in metastatic breast cancer patients who have progressed after prior trastuzumab-based treatments. Clinical cancer research : an official journal of the American Association for Cancer Research. 2004 Academic Article GET IT
Times cited: 58
Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004 Academic Article GET IT
Times cited: 257
Subcutaneously administered recombinant human interleukin-2 and interferon alfa-2a for advanced breast cancer: a phase II study of the Cancer and Leukemia Group B (CALGB 9041). Investigational new drugs. 2004 Academic Article GET IT
Times cited: 8
Benefit of Paclitaxel in estrogen receptor-negative versus estrogen receptor-positive early breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Letter GET IT
A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment. Breast cancer research : BCR. 2003 Academic Article GET IT
Times cited: 761
Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia. Journal of the National Cancer Institute. 2003 Academic Article GET IT
Times cited: 153
A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. The New England journal of medicine. 2003 Academic Article GET IT
Times cited: 1674
Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation. Genome research. 2003 Academic Article GET IT
Times cited: 336
Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy. Cancer. 2003 Academic Article GET IT
Times cited: 253
Factors influencing treatment patterns of breast cancer patients age 75 and older. Critical reviews in oncology/hematology. 2003 Review GET IT
Times cited: 115
Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Academic Article GET IT
Times cited: 57
Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Academic Article GET IT
Times cited: 19
Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Academic Article GET IT
Times cited: 1161
Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Academic Article GET IT
Times cited: 1370
Screening chest imaging studies are not effective in the follow-up of breast cancer patients. The Journal of oncology management : the official journal of the American College of Oncology Administrators. 2003 Academic Article GET IT
Existential concerns in late stage cancer. European journal of oncology nursing : the official journal of European Oncology Nursing Society. 2002 Academic Article GET IT
Prospective exploratory analysis of the association between tumor response, quality of life, and expenditures among patients receiving paclitaxel monotherapy for refractory metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Academic Article GET IT
Times cited: 25
Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. The New England journal of medicine. 2002 Academic Article GET IT
Times cited: 1161
Assessment of molecular markers of clinical sensitivity to single-agent taxane therapy for metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Academic Article GET IT
Times cited: 73
Focus on breast cancer. Cancer cell. 2002 Review GET IT
Times cited: 87
Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3. The Journal of biological chemistry. 2002 Academic Article GET IT
Times cited: 309
Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Academic Article GET IT
Times cited: 403
Association of angiogenesis and disease outcome in node-positive breast cancer patients treated with adjuvant cyclophosphamide, doxorubicin, and fluorouracil: a Cancer and Leukemia Group B correlative science study from protocols 8541/8869. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Academic Article GET IT
Times cited: 22
High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Academic Article GET IT
Times cited: 58
Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a phase II randomized trial of adjuvant dose-dense chemotherapy for women with node-positive breast carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2001 Academic Article GET IT
Times cited: 29
The MORE trial: multiple outcomes for raloxifene evaluation--breast cancer as a secondary end point: implications for prevention. Annals of the New York Academy of Sciences. 2001 Academic Article GET IT
Times cited: 36
Predictive factor for the response to adjuvant therapy with emphasis in breast cancer. Breast cancer research : BCR. 2001 Review GET IT
Times cited: 16
Global tobacco control. Lancet (London, England). 2001 Letter GET IT
Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and Leukemia Group B Study 8662. Clinical cancer research : an official journal of the American Association for Cancer Research. 2001 Academic Article GET IT
Times cited: 96
Modulation of Hsp90 function by ansamycins sensitizes breast cancer cells to chemotherapy-induced apoptosis in an RB- and schedule-dependent manner. See: E. A. Sausville, Combining cytotoxics and 17-allylamino, 17-demethoxygeldanamycin: sequence and tumor biology matters, Clin. Cancer Res., 7: 2155-2158, 2001. Clinical cancer research : an official journal of the American Association for Cancer Research. 2001 Academic Article GET IT
Times cited: 173
High-dose chemotherapy for breast cancer: "how do you know?". Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Editorial Article GET IT
Times cited: 9
Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Academic Article GET IT
Times cited: 545
Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trial. Breast cancer research and treatment. 2001 Academic Article GET IT
Times cited: 193
Phase I study of a third-generation selective estrogen receptor modulator, LY353381.HCL, in metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Academic Article GET IT
Times cited: 78
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. The New England journal of medicine. 2001 Academic Article GET IT
Times cited: 9526
Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: a phase I trial. Proceedings of the National Academy of Sciences of the United States of America. 2001 Academic Article GET IT
Times cited: 196
Social support as a buffer to the psychological impact of stressful life events in women with breast cancer. Cancer. 2001 Academic Article GET IT
Times cited: 191
Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation. Breast cancer research and treatment. 2001 Academic Article GET IT
Times cited: 667
Dose-intensity, dose-escalation, and dose-density in the adjuvant chemotherapy of primary, operable breast cancer. Breast disease. 2001 Academic Article GET IT
Theoretical concepts and the emerging role of taxanes in adjuvant therapy. The oncologist. 2001 Review GET IT
Times cited: 109
Detecting gene copy number fluctuations in tumor cells by microarray analysis of genomic representations. Genome research. 2000 Academic Article GET IT
Times cited: 80
Larry Norton--president-elect of ASCO. American Society of Clinical Oncology. Interviewed by Ezzie Hutchinson. The Lancet. Oncology. 2000 Article GET IT
HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2000 Academic Article GET IT
Microtubule-interfering agents stimulate the transcription of cyclooxygenase-2. Evidence for involvement of ERK1/2 AND p38 mitogen-activated protein kinase pathways. The Journal of biological chemistry. 2000 Academic Article GET IT
Times cited: 294
Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21. Clinical cancer research : an official journal of the American Association for Cancer Research. 2000 Academic Article GET IT
Times cited: 192
Association of angiogenesis in lymph node metastases with outcome of breast cancer. Journal of the National Cancer Institute. 2000 Academic Article GET IT
Times cited: 74
Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. The Journal of cell biology. 2000 Academic Article GET IT
Times cited: 768
Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2000 Academic Article GET IT
Times cited: 680
Estrogen-receptor status in breast cancer. JAMA. 2000 Letter GET IT
Times cited: 1
A pilot study of interpersonal psychotherapy by telephone with cancer patients and their partners. 2000 GET IT
Times cited: 104
An immunotherapeutic approach to treatment of breast cancer: focus on trastuzumab plus paclitaxel. Breast Cancer Medicine Service. Cancer chemotherapy and pharmacology. 2000 Review GET IT
Times cited: 8
Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations. Journal of the National Cancer Institute. 1999 Academic Article GET IT
Times cited: 154
Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer. Seminars in oncology. 1999 Academic Article GET IT
Times cited: 267
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. JAMA. 1999 Academic Article GET IT
Times cited: 1867
Phase II trial of topotecan in advanced breast cancer: a Cancer and Leukemia Group B study. American journal of clinical oncology. 1999 Academic Article GET IT
Times cited: 20
Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1999 Academic Article GET IT
Times cited: 33
5-year results of dose-intensive sequential adjuvant chemotherapy for women with high-risk node-positive breast cancer: A phase II study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1999 Academic Article GET IT
Times cited: 50
Adjuvant breast cancer therapy: current status and future strategies--growth kinetics and the improved drug therapy of breast cancer. Seminars in oncology. 1999 Review GET IT
Times cited: 43
Kinetic concepts in the systemic drug therapy of breast cancer. Seminars in oncology. 1999 Review GET IT
Times cited: 37
Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 1999 Academic Article GET IT
Times cited: 11
Dose-response trial of megestrol acetate in advanced breast cancer: cancer and leukemia group B phase III study 8741. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1999 Academic Article GET IT
Times cited: 38
Sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide for resectable high-risk breast cancer: feasibility and efficacy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1999 Academic Article GET IT
Times cited: 91
Breast cancer advocates in clinical research: a trialist's perspective. Breast disease. 1998 Academic Article GET IT
Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Review GET IT
Times cited: 394
erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer. Journal of the National Cancer Institute. 1998 Academic Article GET IT
Times cited: 549
Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B. Journal of the National Cancer Institute. 1998 Academic Article GET IT
Times cited: 499
Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. Cancer research. 1998 Academic Article GET IT
Times cited: 946
Survival of premenopausal women with breast carcinoma: effects of menstrual timing of surgery. Cancer. 1998 Academic Article GET IT
Times cited: 8
Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet (London, England). 1998 Review GET IT
Times cited: 3938
BRCA-associated breast cancer in young women. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Academic Article GET IT
Times cited: 285
BRCA-associated breast cancer: absence of a characteristic immunophenotype. Cancer research. 1998 Academic Article GET IT
Times cited: 80
Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Academic Article GET IT
Times cited: 47
The epidermal growth factor receptor modulates the interaction of E-cadherin with the actin cytoskeleton. The Journal of biological chemistry. 1998 Academic Article GET IT
Times cited: 222
Lack of increased cardiac toxicity with sequential doxorubicin and paclitaxel. Cancer investigation. 1998 Academic Article GET IT
Times cited: 10
Pulmonary toxicity of high-dose chemotherapy for breast cancer: a non-invasive approach to diagnosis and treatment. Bone marrow transplantation. 1997 Academic Article GET IT
Times cited: 36
Phase II study of semisynthetic paclitaxel in metastatic breast cancer. European journal of cancer (Oxford, England : 1990). 1997 Academic Article GET IT
Times cited: 14
BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA. 1997 Academic Article GET IT
Times cited: 349
Dose-dense therapy with paclitaxel via weekly 1-hour infusion: preliminary experience in the treatment of metastatic breast cancer. Seminars in oncology. 1997 Academic Article GET IT
Times cited: 18
Conceptual basis for advances in the systemic drug therapy of breast cancer. Seminars in oncology. 1997 Review GET IT
Times cited: 24
Evolving concepts in the systemic drug therapy of breast cancer. Seminars in oncology. 1997 Review GET IT
Times cited: 145
Innovative approaches to the treatment of advanced breast cancer: introduction. Seminars in oncology. 1997 Academic Article GET IT
Times cited: 4
A stereotactic stand-off. American journal of surgery. 1997 Editorial Article GET IT
HER2 overexpression and paclitaxel sensitivity in breast cancer: therapeutic implications. Oncology (Williston Park, N.Y.). 1997 Review GET IT
Times cited: 149
Paclitaxel for breast cancer: the Memorial Sloan-Kettering Cancer Center experience. Oncology (Williston Park, N.Y.). 1997 Review GET IT
Times cited: 19
Truth, science, and the oncologist. Annals of the New York Academy of Sciences. 1997 Academic Article GET IT
Adjuvant Drug Treatment for Resectable Breast Cancer. The oncologist. 1997 Academic Article GET IT
Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1997 Academic Article GET IT
Times cited: 266
Prevalence of recurring BRCA mutations among Ashkenazi Jewish women with breast cancer. Genetic testing. 1997 Academic Article GET IT
Times cited: 47
Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nature medicine. 1996 Review GET IT
Times cited: 278
Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers. Journal of the National Cancer Institute. 1996 Review GET IT
Times cited: 640
The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nature genetics. 1996 Academic Article GET IT
Times cited: 334
Adjuvant drug therapy for operable breast cancer. Seminars in oncology. 1996 Review GET IT
Times cited: 27
Management of advanced breast cancer: patient needs, challenges and new treatment options. Introduction. Anti-cancer drugs. 1996 Academic Article GET IT
Germline BRCA1 185delAG mutations in Jewish women with breast cancer. Lancet (London, England). 1996 Academic Article GET IT
Times cited: 135
Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
Times cited: 154
Psychological symptoms and disease-free and overall survival in women with stage II breast cancer. Cancer and Leukemia Group B. Journal of the National Cancer Institute. 1996 Academic Article GET IT
Times cited: 91
Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
Times cited: 49
Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nature genetics. 1996 Academic Article GET IT
Times cited: 258
Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
Times cited: 1276
Sequential adjuvant therapy: the Memorial Sloan-Kettering Cancer Center experience. Seminars in oncology. 1996 Academic Article GET IT
Times cited: 28
Immunophenotype of intraductal carcinoma. Archives of pathology & laboratory medicine. 1996 Academic Article GET IT
Times cited: 82
Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
Times cited: 148
The impact of the sequence of radiation and chemotherapy on local control after breast-conserving surgery. The cancer journal from Scientific American. 1996 Academic Article GET IT
Times cited: 22
Does administration of chemotherapy before radiotherapy in breast cancer patients treated with conservative surgery negatively impact local control?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1995 Academic Article GET IT
Times cited: 72
High-dose chemotherapy of breast cancer. The Canadian journal of oncology. 1995 Review GET IT
Microdissection and molecular genetic analysis of HER2/neu in breast carcinoma. The American journal of surgical pathology. 1995 Academic Article GET IT
Times cited: 21
Refining the origins of breast cancer. Nature medicine. 1995 Comment GET IT
Times cited: 1
Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes. Seminars in oncology. 1995 Academic Article GET IT
Times cited: 23
Rapidly cycled courses of high-dose alkylating agents supported by filgrastim and peripheral blood progenitor cells in patients with metastatic breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 1995 Academic Article GET IT
Times cited: 18
Memorial Sloan-Kettering Cancer Center experience with paclitaxel in the treatment of breast cancer. Seminars in oncology. 1995 Review GET IT
Times cited: 5
Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1995 Academic Article GET IT
Times cited: 209
Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factor. Journal of the National Cancer Institute. 1995 Academic Article GET IT
Times cited: 86
Sources of anticipatory emotional distress in women receiving chemotherapy for breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology. 1995 Academic Article GET IT
Times cited: 27
Memorial Sloan-Kettering Cancer Center experience with paclitaxel in the treatment of breast cancer: from advanced disease to adjuvant therapy. Seminars in oncology. 1995 Academic Article GET IT
Times cited: 25
Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1995 Academic Article GET IT
Times cited: 56
Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracycline response. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1995 Academic Article GET IT
Times cited: 218
A phase II trial of extracorporeal plasma immunoadsorption of patient plasma with PROSORBA columns for treating metastatic breast cancer. Cancer. 1995 Academic Article GET IT
Times cited: 14
Carboplatin and etoposide in metastatic breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology. 1995 Letter GET IT
Times cited: 2
p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1995 Academic Article GET IT
Times cited: 129
Immunohistochemical detection of HER2/neu in patients with axillary lymph node negative breast carcinoma. A study of epidemiologic risk factors, histologic features, and prognosis. Cancer. 1995 Academic Article GET IT
Times cited: 114
A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. JAMA. 1995 Academic Article GET IT
Times cited: 420
Conditioned emotional distress in women receiving chemotherapy for breast cancer. Journal of consulting and clinical psychology. 1995 Academic Article GET IT
Times cited: 31
Are axillary recurrence and overall survival affected by axillary extranodal tumor extension in breast cancer? Implications for radiation therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1995 Academic Article GET IT
Times cited: 76
High-dose chemotherapy of breast cancer: current status and developmental strategies. European journal of cancer (Oxford, England : 1990). 1995 Academic Article GET IT
Times cited: 5
Potential strategies for improving the results of high-dose chemotherapy in patients with metastatic breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology. 1995 Review GET IT
Times cited: 19
Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients. Bone marrow transplantation. 1994 Academic Article GET IT
Times cited: 22
Simultaneous dose escalation and schedule intensification of carboplatin-based chemotherapy using peripheral blood progenitor cells and filgrastim: a phase I trial. Cancer research. 1994 Academic Article GET IT
Times cited: 21
Optimization of conditions for ex vivo expansion of CD34+ cells from patients with stage IV breast cancer. Blood. 1994 Academic Article GET IT
Times cited: 81
Taxol (paclitaxel) plus recombinant human granulocyte colony-stimulating factor in the treatment of metastatic breast cancer. Oncology. 1994 Academic Article GET IT
Times cited: 3
Salvage chemotherapy of breast cancer. Seminars in oncology. 1994 Review GET IT
Times cited: 24
Symptom prevalence, characteristics and distress in a cancer population. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 1994 Academic Article GET IT
Times cited: 533
Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma. The New England journal of medicine. 1994 Academic Article GET IT
Times cited: 648
High-intensity chemotherapy with peripheral blood progenitor cell support. Seminars in oncology. 1994 Review GET IT
Times cited: 16
Immunohistochemical detection of cathepsin D in T2N0M0 breast carcinoma. The American journal of surgical pathology. 1994 Academic Article GET IT
Times cited: 35
Re: "We may be lost, but we're sure makin' good time". Cancer investigation. 1994 Letter GET IT
Taxol (paclitaxel): a novel anti-microtubule agent with remarkable anti-neoplastic activity. International journal of clinical & laboratory research. 1994 Review GET IT
Times cited: 86
The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. European journal of cancer (Oxford, England : 1990). 1994 Academic Article GET IT
Times cited: 1190
[Kinetics of breast neoplasms]. Minerva medica. 1994 Review GET IT
Times cited: 2
Use of ultrasound to guide radiation boost planning following lumpectomy for carcinoma of the breast. International journal of radiation oncology, biology, physics. 1993 Academic Article GET IT
Times cited: 33
High-intensity chemotherapy with hematopoietic support in breast cancer. Annals of the New York Academy of Sciences. 1993 Review GET IT
Times cited: 5
Kinetic concepts in the treatment of breast cancer. Annals of the New York Academy of Sciences. 1993 Review GET IT
Times cited: 12
Taxol and recombinant human granulocyte colony-stimulating factor, an active regimen as initial therapy for metastatic breast cancer. A preliminary report. Annals of the New York Academy of Sciences. 1993 Academic Article GET IT
Times cited: 2
Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1993 Academic Article GET IT
Times cited: 75
Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1993 Academic Article GET IT
Times cited: 239
Formation of food aversions in cancer patients receiving repeated infusions of chemotherapy. Behaviour research and therapy. 1993 Academic Article GET IT
Times cited: 36
Milk fistula: a complication after core breast biopsy. 1993 GET IT
Times cited: 91
Systemic adjuvant therapy for breast cancer. Current opinion in oncology. 1993 Review GET IT
Times cited: 4
Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies. Journal of the National Cancer Institute. 1993 Academic Article GET IT
Times cited: 406
Phase I trial of granulocyte-macrophage colony-stimulating factor plus high-dose cyclophosphamide given every 2 weeks: a Cancer and Leukemia Group B study. Journal of the National Cancer Institute. 1993 Academic Article GET IT
Times cited: 39
Preliminary experience with paclitaxel (Taxol) plus recombinant human granulocyte colony-stimulating factor in the treatment of breast cancer. Seminars in oncology. 1993 Academic Article GET IT
Times cited: 45
Modeling the development of metastases from primary and locally recurrent tumors: comparison with a clinical data base for prostatic cancer. Cancer research. 1993 Academic Article GET IT
Times cited: 69
High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1993 Academic Article GET IT
Times cited: 531
Rapid administration of multiple cycles of high-dose myelosuppressive chemotherapy in patients with metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1993 Academic Article GET IT
Times cited: 74
Phase II trial of carboplatin and etoposide in metastatic breast cancer. Cancer. 1993 Academic Article GET IT
Times cited: 14
An intensive sequenced adjuvant chemotherapy regimen for breast cancer. Cancer investigation. 1993 Academic Article GET IT
Times cited: 9
Kinetic concepts in the treatment of breast cancer. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 1993 Review GET IT
Times cited: 6
Timing of radiotherapy in the treatment of early-stage breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1993 Letter GET IT
Times cited: 14
Rapid delivery of multiple high-dose chemotherapy courses with granulocyte colony-stimulating factor and peripheral blood-derived hematopoietic progenitor cells. Journal of the National Cancer Institute. 1992 Letter GET IT
Times cited: 35
Precholecystectomy endoscopic cholangiography and stone removal is not superior to cholecystectomy, cholangiography, and common duct exploration. American journal of surgery. 1992 Academic Article GET IT
Times cited: 140
An experimental analysis of classically conditioned nausea during cancer chemotherapy. Psychosomatic medicine. 1992 Academic Article GET IT
Times cited: 54
Chemotherapy for urothelial tract malignancies: breaking the deadlock. Seminars in surgical oncology. 1992 Review GET IT
Times cited: 40
Evolving concepts in the adjuvant systemic therapy of operable breast cancer. Cancer treatment and research. 1992 Review GET IT
Metastatic breast cancer. Length and quality of life. The New England journal of medicine. 1991 Editorial Article GET IT
Times cited: 27
A prospective study of incisional time, blood loss, pain, and healing with carbon dioxide laser, scalpel, and electrosurgery. Archives of surgery (Chicago, Ill. : 1960). 1991 Academic Article GET IT
Times cited: 44
Prediction of prognosis in primary breast cancer by detection of a high molecular weight mucin-like antigen using monoclonal antibodies DF3, F36/22, and CU18: a Cancer and Leukemia Group B study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1991 Academic Article GET IT
Times cited: 71
Decision for surgical management of perforation following endoscopic sphincterotomy. The American surgeon. 1991 Academic Article GET IT
Times cited: 47
Adjuvant systemic therapy for early breast cancer. Seminars in surgical oncology. 1991 Review GET IT
Times cited: 2
Chemotherapy of metastatic Merkel cell cancer. Cancer investigation. 1991 Review GET IT
Times cited: 42
Minimal access surgery for gastroesophageal reflux: laparoscopic placement of the Angelchik prosthesis in pigs. Surgical endoscopy. 1991 Academic Article GET IT
Times cited: 19
Potential innovations in scheduling of cancer chemotherapy. Important advances in oncology. 1991 Review GET IT
Times cited: 48
The next step. Surgery. 1991 Editorial Article GET IT
Times cited: 3
Trimetrexate in untreated and previously treated patients with metastatic breast cancer: a Cancer and Leukemia Group B study. Medical and pediatric oncology. 1991 Academic Article GET IT
Times cited: 12
Resident training. Archives of surgery (Chicago, Ill. : 1960). 1990 Letter GET IT
A randomized comparison of methotrexate dose and the addition of bleomycin to CHOP therapy for diffuse large cell lymphoma and other non-Hodgkin's lymphomas. Cancer and Leukemia Group B study 7851. Cancer. 1990 Academic Article GET IT
Times cited: 19
The surgical management of atypical mycobacterial soft-tissue infections. 1990 GET IT
Times cited: 49
Clinical cardiotoxicity of esorubicin (4'-deoxydoxorubicin,DxDx): prospective studies with serial gated heart scans and reports of selected cases. A Cancer and Leukemia Group B report. 1990 GET IT
Times cited: 6
Insulin protects against muscle proteolysis induced by septic plasma. Archives of surgery (Chicago, Ill. : 1960). 1990 Academic Article GET IT
Chemotherapy for large cell lymphoma: a status update. Seminars in oncology. 1990 Review GET IT
Times cited: 34
Biology of residual breast cancer after therapy: a kinetic interpretation. Progress in clinical and biological research. 1990 Review GET IT
Times cited: 4
Endoscopic versus operative gastrostomy: final results of a prospective randomized trial. Gastrointestinal endoscopy. 1990 Academic Article GET IT
Times cited: 205
Phase II study of MOPLACE chemotherapy for patients with previously treated Hodgkin's disease: a CALGB study. Medical and pediatric oncology. 1990 Academic Article GET IT
Times cited: 18
Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: a Cancer and Leukemia Group B Study. The American journal of medicine. 1989 Academic Article GET IT
Times cited: 89
Effect of cancer plasma on skeletal muscle metabolism. The Journal of surgical research. 1989 Academic Article GET IT
Times cited: 5
Endoscopic cholangiography and stone removal prior to cholecystectomy. A more cost-effective approach than operative duct exploration?. Archives of surgery (Chicago, Ill. : 1960). 1989 Academic Article GET IT
Times cited: 56
A good offense. Surgery. 1989 Editorial Article GET IT
Times cited: 1
A Gompertzian model of human breast cancer growth. Cancer research. 1988 Academic Article GET IT
Times cited: 569
Needle localization breast biopsy: accuracy versus cost. American journal of surgery. 1988 Review GET IT
Times cited: 19
Accuracy and cost of needle localization breast biopsy. Archives of surgery (Chicago, Ill. : 1960). 1988 Academic Article GET IT
Times cited: 58
Cancer plasma effects on skeletal muscle metabolism. Current surgery. 1988 Academic Article GET IT
Implications of growth kinetic concepts for cancer chemoprevention. Cancer investigation. 1988 Review GET IT
Operative versus endoscopic gastrostomy. Preliminary results of a prospective randomized trial. American journal of surgery. 1988 Academic Article GET IT
Times cited: 33
A phase I-II study of intensive-dose adriamycin for advanced breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1987 Academic Article GET IT
Times cited: 118
A randomized trial of high-dose methotrexate versus standard-dose methotrexate following cyclophosphamide, doxorubicin (adriamycin), vincristine, and prednisone with or without bleomycin in the therapy of diffuse large cell lymphoma: preliminary report of Cancer and Leukemia Group B Study 7851. NCI monographs : a publication of the National Cancer Institute. 1987 Academic Article GET IT
Times cited: 11
Hyperglycemic complications associated with adjuvant chemotherapy of breast cancer. A cancer and leukemia group B (CALGB) study. 1986 GET IT
Duodenojejunostomy for the pancreaticobiliary complications of duodenal diverticulum. Annals of surgery. 1986 Letter GET IT
Times cited: 1
The Norton-Simon hypothesis revisited. Cancer treatment reports. 1986 Academic Article GET IT
Times cited: 395
Implications of kinetic heterogeneity in clinical oncology. Seminars in oncology. 1985 Review GET IT
Times cited: 78
Treatment of refractory Hodgkin's disease with teniposide, cisplatin, hexamethylmelamine, and prednisolone: cancer and leukemia group B trial 8171. Cancer treatment reports. 1985 Academic Article GET IT
Times cited: 8
Does drainage of intraabdominal pus reverse multiple organ failure?. American journal of surgery. 1985 Academic Article GET IT
Times cited: 86
Thoughts on the surgical staging of lymphomas. The Mount Sinai journal of medicine, New York. 1985 Academic Article GET IT
Tumor growth kinetics. The Mount Sinai journal of medicine, New York. 1985 Academic Article GET IT
Times cited: 2
Pharmacokinetics of vindesine given as an intravenous bolus and 24-hour infusion in humans. Cancer research. 1985 Academic Article GET IT
Times cited: 13
Accuracy of aspiration cytology in detecting breast cancer. Surgery. 1984 Academic Article GET IT
Times cited: 40
Hemicorporectomy--perioperative management: a case presentation and review of literature. 1984 GET IT
Times cited: 10
Experimental and clinical activity of mitomycin C and cis-diamminedichloroplatinum in malignant mesothelioma. Cancer research. 1984 Academic Article GET IT
Times cited: 50
Therapeutic leukapheresis for hyperleukocytosis in acute myelocytic leukemia. Medical and pediatric oncology. 1983 Academic Article GET IT
Times cited: 59
Utility of thyroid aspiration biopsy. Surgery. 1982 Academic Article GET IT
Times cited: 18
Diffuse malignant mesothelioma. Prospective evaluation of 69 patients. Annals of internal medicine. 1982 Academic Article GET IT
Times cited: 302
A lump in the breast: assessment and options for local treatment. Arizona medicine. 1982 Academic Article GET IT
Needle aspiration biopsy of thyroid nodules. Arizona medicine. 1981 Academic Article GET IT
Outcome of operations for upper gastrointestinal tract bleeding. Archives of surgery (Chicago, Ill. : 1960). 1980 Academic Article GET IT
Times cited: 9
Nodular histiocytic lymphoma: an aggressive nodular lymphoma with potential for prolonged disease-free survival. Blood. 1980 Academic Article GET IT
Times cited: 41
Small bowel neomucosa. The Journal of surgical research. 1980 Academic Article GET IT
Times cited: 45
Selective intra-arterial vasopression in fusion for upper gastrointestinal tract hemorrhage: a controlled trial. Archives of surgery (Chicago, Ill. : 1960). 1980 Academic Article GET IT
Times cited: 63
Massive cecal dilation: pseudoobstruction versus cecal volvulus? 1979 GET IT
Times cited: 26
Caroli's: a surgical challenge. 1979 GET IT
Times cited: 3
Preventing bile reflux by intussusception gastroduodenostomy. The Journal of surgical research. 1978 Academic Article GET IT
Times cited: 1
Gastric ulcers following vagotomy in piglets. World journal of surgery. 1978 Academic Article GET IT
Times cited: 1
Depression of cell-mediated immunity in diabetes. Archives of surgery (Chicago, Ill. : 1960). 1978 Academic Article GET IT
Times cited: 40
Accuracy of techniques to detect intraperitoneal abscess. Surgery. 1978 Academic Article GET IT
Times cited: 27
Lack of therapeutic synergism between vincristine and methotrexate in L1210 murine leukemia in vivo. Cancer treatment reports. 1978 Academic Article GET IT
Times cited: 14
Condyloma. A new epidemic. Archives of surgery (Chicago, Ill. : 1960). 1978 Academic Article GET IT
Times cited: 10
The continuing challenge of duodenal injuries. The Journal of trauma. 1978 Academic Article GET IT
Times cited: 39
Immunologic studies of canine lymphosarcoma: mixed leukocyte reactivity following chemotherapy. Clinical immunology and immunopathology. 1978 Academic Article GET IT
Times cited: 3
Statistical considerations in determination of ventricular volume from echocardiographic and angiographic data. The American journal of cardiology. 1978 Letter GET IT
Repair of non-unions by pulsing electromagnetic fields. Acta orthopaedica Belgica. 1978 Review GET IT
Times cited: 61
The treatment of combination chemotherapy-resistant Hodgkin disease with single-agent vinblastine. American journal of hematology. 1978 Academic Article GET IT
Times cited: 7
Clinical indications and accuracy of gray scale ultrasonography in the patient with suspected biliary tract disease. American journal of surgery. 1977 Academic Article GET IT
Times cited: 20
Hepatic support with hepatocyte suspensions in a permeable membrane dialyzer. Surgery. 1977 Academic Article GET IT
Times cited: 49
Tumor size, sensitivity to therapy, and design of treatment schedules. Cancer treatment reports. 1977 Academic Article GET IT
Times cited: 449
Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term followup. Cancer treatment reports. 1977 Academic Article GET IT
Times cited: 135
Growth curve of an experimental solid tumor following radiotherapy. Journal of the National Cancer Institute. 1977 Academic Article GET IT
Times cited: 110
Migration of transfused granulocytes in leukopenic dogs. Blood. 1977 Academic Article GET IT
Times cited: 18
Multiple organ failure. Surgery, gynecology & obstetrics. 1977 Academic Article GET IT
Times cited: 267
Effect of prior radiotherapy on tolerance and response to chemotherapy in non-Hodgkin's lymphoma. American journal of hematology. 1977 Academic Article GET IT
Times cited: 5
Predicting the course of Gompertzian growth. Nature. 1976 Academic Article GET IT
Times cited: 250
Community experience with small bowel bypass for morbid obesity. American journal of surgery. 1976 Academic Article GET IT
Times cited: 5
Morbidity of colostomy closure. American journal of surgery. 1976 Academic Article GET IT
Times cited: 64
Depressed cellular immunity in diabetics. Surgical forum. 1976 Academic Article GET IT
Times cited: 3
Hepatocyte perfusion within a centrifuge. Surgery, gynecology & obstetrics. 1976 Academic Article GET IT
Times cited: 28
Accuracy of ultrasound in diagnosing abdominal masses. Archives of surgery (Chicago, Ill. : 1960). 1975 Academic Article GET IT
Times cited: 24
Massive right upper quadrant intra-abdominal injury requiring pancreaticoduodenectomy and partial hepatectomy. The Journal of trauma. 1975 Academic Article GET IT
Times cited: 12
Cholecystectomy with and without surgical drainage. American journal of surgery. 1975 Academic Article GET IT
Times cited: 31
Liver failure in the postoperative patient: the role of sepsis and immunologic deficiency. Surgery. 1975 Academic Article GET IT
Times cited: 52
Incidental appendicectomy with laparotomy for trauma. The British journal of surgery. 1975 Academic Article GET IT
Times cited: 8
Current management of upper gastrointestinal bleeding. Annals of surgery. 1975 Academic Article GET IT
Times cited: 18
Operative choice and technique following pancreatic injury. Archives of surgery (Chicago, Ill. : 1960). 1975 Academic Article GET IT
Times cited: 39
Replacement of portal vein during pancreatectomy for carcinoma. Surgery. 1975 Academic Article GET IT
Times cited: 67
Gastric mucosal ischemia in experimental stress ulcer. The Journal of surgical research. 1975 Academic Article GET IT
Times cited: 24
Growing small-bowel mucosa: an experimental approach to the short-bowel syndrome. Surgical forum. 1975 Academic Article GET IT
Times cited: 7
Gastric mucosal blood flow measurement. The Journal of surgical research. 1974 Academic Article GET IT
Times cited: 3
The effects of brain stem compression on the heart. Surgical neurology. 1974 Academic Article GET IT
Times cited: 3
Management of pseudo-obstruction of the colon. Surgery, gynecology & obstetrics. 1974 Academic Article GET IT
Times cited: 44
Pharmacological protection against swine stress ulcer. Gastroenterology. 1974 Academic Article GET IT
Times cited: 19
Resident-prepared audio-visual programs for teaching operative technique. The Journal of surgical research. 1974 Academic Article GET IT
Times cited: 1
Near total pancreatectomy for hemorrhagic pancreatitis. American journal of surgery. 1974 Academic Article GET IT
Times cited: 43
Injuries associated with renal trauma. The Journal of urology. 1973 Academic Article GET IT
Times cited: 17
Bile reflux in experimental stress ulcer. Surgery. 1973 Academic Article GET IT
Times cited: 25
Gastric blood flow in endotoxin-induced stress ulcer. Archives of surgery (Chicago, Ill. : 1960). 1973 Academic Article GET IT
Times cited: 48
Training foreign academicians in U.S. medical schools. The Journal of surgical research. 1973 Academic Article GET IT
Growth, inhibition and suppression of mouse melanoma on the isolated perfused pig spleen. Review of surgery. 1973 Academic Article GET IT
Liver failure in the surgical patient. Bulletin de la Societe internationale de chirurgie. 1973 Academic Article GET IT
A new venous prosthesis. Surgery. 1972 Academic Article GET IT
Times cited: 217
A swine stress ulcer model. Annals of surgery. 1972 Academic Article GET IT
Times cited: 18
Cardiovascular effects of increased intracranial pressure. Surgical forum. 1972 Academic Article GET IT
Gastric secretory response to pressure on vagal nuclei. American journal of surgery. 1972 Academic Article GET IT
Times cited: 13
Immunologic response to melanoma of sensitized perfused bone and spleen. Journal of surgical oncology. 1972 Academic Article GET IT
Metabolic and immunologic studies of perfused bone in vitro. The Journal of bone and joint surgery. American volume. 1972 Academic Article GET IT
Times cited: 1
Cyclic adenosine 3', monophosphate 5', thyrocalcitonin, parathyroid hormone, and the isolated perfused bone. Surgical forum. 1971 Academic Article GET IT
Growth, inhibition and suppression of mouse melanoma on isolated perfused pig spleen. Surgical forum. 1971 Academic Article GET IT
Times cited: 1
Gastric secretory response to head injury. Archives of surgery (Chicago, Ill. : 1960). 1970 Academic Article GET IT
Times cited: 50
Prolonged experimental bone perfusion. Surgical forum. 1970 Academic Article GET IT
Times cited: 1
LONG-TERM COMPARISON OF VEIN PATCH WITH DIRECT SUTURE. TECHNIQUE OF ANASTOMOSIS OF SMALL ARTERIES. Archives of surgery (Chicago, Ill. : 1960). 1964 Academic Article GET IT
Times cited: 11
THE ROLE OF SURGERY IN CARCINOMA OF THE UTERINE CERVIX. The Journal of the Kentucky Medical Association. 1964 Academic Article GET IT
Coronary artery patch graft. Experiment with cardiopulmonary bypass and hypothermia. Archives of surgery (Chicago, Ill. : 1960). 1963 Academic Article GET IT
Times cited: 1

more ...

less ...

Background

education and training

M.D., Columbia University College of Physicians and Surgeons 1972
A.B., University of Rochester 1968

Contact

full name

Larry Norton

VIVO Weill Cornell Medical College

Larry Norton Professor of Medicine

Publications

selected publications

Background

education and training

Contact

full name

Phone

Publications

selected publications

Background

education and training

Contact

full name